ISF Consortium Study Journey

Consortium for clinical trials

Study Journey

The lifecycle of a clinical trial

Four specialised partners, one continuous process. From the first enquiry to audit-proof archiving, we support clinical trials across every phase – compliant, documented, from a single source.

5
phases
4
partners
7
ongoing services

Sequence

Five phases, one continuous process

Every clinical trial passes through the same stations. We cover all of them – with clear responsibilities at each handover.

  1. 01

    Preparation

    Feasibility assessment, costing and contracting – the decisions that shape the timeline and quality of the entire trial.

    • Enquiry
    • Feasibility
    • Budget/contract
  2. 02

    Approval

    Submission to competent authorities and the ethics committee, compilation of study documents and site initiation.

    • Authority
    • Ethics committee
    • Initiation
  3. 03

    Recruitment

    Identifying eligible patients, obtaining informed consent in line with GCP and enrolling them into the trial.

    • Screening
    • Informed consent
    • Randomisation
  4. 04

    Conduct

    The longest phase: treatment per protocol, investigational product handling, monitoring, pharmacovigilance and ongoing documentation.

    • Treatment
    • IMP handling
    • Monitoring
    • Safety
    • Documentation
    • Document maintenance
  5. 05

    Close-out

    Close-out visit, audit-proof archiving for the statutory retention periods and documented destruction.

    • Close-out
    • Archiving
    • Destruction

Stakeholders

Who hands over when

The trial chain from sponsor to close-out – the CRO coordinates between the site and the data flow.

  1. Sponsor
  2. Trial site
  3. Patient
  4. Data
  5. Close-out
CRO

coordinates site, patient data and feedback to the sponsor

Continuous

Ongoing services across all phases

These services do not run sequentially – they run in parallel to every phase of the study journey.

  • Quality management
  • Regulatory affairs
  • Training
  • Digital study documentation
  • Data management
  • Quality assurance
  • Compliance

Consortium

The four partners

Four independent companies with clearly delineated competencies – together they cover the complete study journey.

  • D·M·I GROUP

    Your partner for clinical research and development.

    D·M·I supports pharma, biotech and medtech companies in planning and conducting clinical trials – worldwide and to the highest quality standards.

  • Good Clinical Practice

    Your specialists for GCP and research services.

    Good Clinical Practice provides hands-on training, audits and consulting for GCP compliance and regulatory requirements.

  • IFKS

    Knowledge that advances. People who make a difference.

    IFKS imparts medical knowledge and fosters exchange – for better care tomorrow.

  • studio.201

    Digital solutions for research and study management.

    studio.201 develops tailor-made software solutions for clinical trials – secure, flexible and future-proof.

Contact

Planning a clinical trial?

Get in touch – we will clarify feasibility, timeline and responsibilities in an initial conversation.

Prefer to email us directly? info@studyjourney.201.de

Send an enquiry

* required